Welcome to chemicalbook!
+1 (818) 612-2111
RFQ
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

RFQ
skype
MY Account
Top
Postion:Product Catalog >Palbociclib Impurity 104
Palbociclib Impurity 104
  • Palbociclib Impurity 104
  • Palbociclib Impurity 104
  • Palbociclib Impurity 104
  • Palbociclib Impurity 104
  • Palbociclib Impurity 104

Palbociclib Impurity 104 NEW

Price Get Latest Price
Package 10mg 50mg 100mg
Min. Order: 10mg
Supply Ability: 1000
Update Time: 2025-07-31

Product Details

Product Name: Palbociclib Impurity 104 CAS No.: 1023594-50-4
Min. Order: 10mg Purity: 99%+ HPLC
Supply Ability: 1000 Release date: 2025/07/31
Molecular Formula: C14H22N4O2

Palbociclib Impurity;1023594-50-4

Article illustration

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com

Product Information

  • Product Code:P005104

  • English Name:Palbociclib Impurity 104

  • English Alias:tert-butyl 4-(4-aminopyridin-3-yl)piperazine-1-carboxylate

  • CAS No.:1023594-50-4

  • Molecular Formula:C₁₄H₂₂N₄O₂

  • Molecular Weight:278.35

Advantages

  • High-Purity Reference Standard:Confirmed by HPLC (≥99.0%), NMR (1H, 13C), HRMS, and elemental analysis, suitable for Palbociclib impurity analysis and quality control.

  • Stability Assurance:Stable for 36 months at -20℃ under light-protected, sealed storage; degradation rate <0.3% in methanol-water mixture within 6 months.

Applications

  • Quality Control Testing:Used for UPLC-MS/MS detection of Impurity 104 in Palbociclib API and formulations, controlling content to meet ICH Q3A standards (single impurity limit ≤0.1%).

  • Process Optimization Research:Monitors impurity formation during Palbociclib synthesis, reducing generation by >35% by adjusting tert-butoxycarbonyl protection temperature (e.g., 0-5℃) and deprotection conditions.

  • Method Validation:Serves as a standard for developing impurity detection methods, verifying UPLC resolution (≥3.0) and LOD (0.01 ng/mL).

Background Description

Palbociclib, the first global CDK4/6 inhibitor, is used for combined therapy of HR+/HER2- advanced breast cancer, inhibiting tumor proliferation by blocking cell cycle transition from G1 to S phase. Impurity 104, a key intermediate impurity in its synthesis, may originate from incomplete amino protection of piperazine rings or amination side reactions of pyridine rings. Its tert-butoxycarbonyl, piperazine ring, and amino group may affect drug synthesis yield, metabolic pathways, and safety. Strict impurity control for anticancer drugs is critical to patient safety, making research on this impurity essential for drug quality control.

Research Status

  • Detection Technology:UPLC-MS/MS with C18 column (1.7μm) and 0.1% formic acid-acetonitrile gradient elution achieves separation within 8 minutes, with LOD of 0.005 ng/mL for high-precision trace impurity analysis.

  • Formation Mechanism:Formed by reaction of 4-(4-nitropyridin-3-yl)piperazine with di-tert-butyl dicarbonate under alkaline conditions (e.g., triethylamine); optimizing reaction temperature and base dosage inhibits side reactions.

  • Safety Evaluation:In vitro cytotoxicity shows IC₅₀ of 205.6 μM against MCF-7 cells (Palbociclib IC₅₀=8.7 μM), with lower toxicity than the main drug but requiring strict content control. Long-term stability testing is ongoing to monitor de-tert-butylation degradation under high temperature (40℃) and high humidity (75%RH) conditions


We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!

WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com


NEW IN STOCK!

The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery! 



Company Profile Introduction

-

You may like

Recommended supplier

Product name Price   Suppliers Update time
$0.00/10mg
VIP2Y
ShenZhen H&D Pharmaceutical Technology Co., LTD
2024-08-12
$0.00/5mg
VIP1Y
Guangzhou Tosun Pharmaceutical Ltd
2025-02-18
$0.00/1g
VIP3Y
Hangzhou ICH Biofarm Co., Ltd
2023-06-12
INQUIRY